BTG3 and myeloid sarcoma: As neuropsychiatric symptoms may be the first clinical manifestation of rheumatic diseases with involvement of the central nervous system (RDwCNS) and inflammatory CSF alterations and MS-like lesions in MRI are frequent, the differential diagnosis between RDwCNS and ANA-positive MS is difficult.